Oral formulations of digestive enzymes such as amylase, lipase, and protease for treating exocrine pancreatic insufficiency and maldigestion. Produced by biotech and pharmaceutical firms for distribution to hospitals, gastroenterology departments, and retail pharmacies serving patients with cystic fibrosis or post-pancreatic